XML 33 R21.htm IDEA: XBRL DOCUMENT v3.22.1
Stock Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of stock-based compensation expense stock options and warrants
   Year Ended
December 31,
2021		   Year Ended
December 31,
2020		 
Research and development  $459,492   $140,278 
General and administrative   3,088,876    2,046,871 
   $3,548,368   $2,187,149 

 
Schedule of fair value of employee stock options
   Ended
December 31,
2021		   Year Ended
December 31,
2020		 
Weighted average exercise price  $8.86   $10.42 
Weighted average grant date fair value  $6.83   $9.25 
Assumptions          
Expected volatility   89-97%    87-91%
Expected term (in years)   6.0-10.0    6.3-10 
Risk-free interest rate   0.81-1.55%    0.36-1.47%
Expected dividend yield   0.00%   0.00%

 
Schedule of stock option activity
  

Number of

Shares

   Weighted-Average
Exercise Prices		   Weighted-Average Remaining Contractual Term (In Years)   Intrinsic Value 
Outstanding at January 1, 2020   2,139,078   $3.46    9.17   $4,052,512 
Granted   782,045    10.42    
—
    
—
 
Exercised   (285,003)   2.74    
—
    
—
 
Cancelled   (25,625)   4.86    —    — 
Outstanding at December 31, 2020   2,610,495   $5.63    8.60   $22,789,233 
Granted   535,500    8.86    —    — 
Exercised   (252,156)   2.74    —    — 
Outstanding at December 31, 2021   2,893,839   $6.48    8.05   $9,932,413 
Exercisable at December 31, 2021   1,219,841   $4.91    7.46   $5,730,660